ZymoGenetics, Inc.'s Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
Xconomy.com -- One of the key people who transformed ZymoGenetics from a basic research institute into a more balanced biotech company with both R and D, has set up shop in a rival startup just a few blocks away on Seattleās Eastlake Avenue. If he plays his cards right, this little company will surpass his former employer, with what he hopes will be an even better treatment to control bleeding.